National Cancer Institute National Cancer Institute
U.S. National Institutes of Health National Cancer Institute
NCI Home Cancer Topics Clinical Trials Cancer Statistics Research & Funding News About NCI
NCI Drug Dictionary
Page Options
Print This Page  Print This Page
Quick Links
Director's Corner
Updates from the Director

Dictionary of Cancer Terms
Cancer-related terms

NCI Drug Dictionary
Definitions, names, and links

Funding Opportunities
Research and training

NCI Publications
Order/download free booklets

Advisory Boards and Groups
Information, meetings, reports

Science Serving People
Learn more about NCI

Español
Información en español
NCI Highlights
Virtual and Standard Colonoscopy Both Accurate

NCI Responds to Hurricanes

The Nation's Investment in Cancer Research FY 2009

Cancer Trends Progress Report: 2007 Update

Past Highlights
You CAN Quit Smoking Now!
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

meropenem
A broad-spectrum carbapenem with antibacterial properties, synthetic Meropenem inhibits cell wall synthesis in gram-positive and gram-negative bacteria. It penetrates cell walls and binds to penicillin-binding protein targets. Meropenem acts against aerobes and anaerobes including Klebsiella, E. coli, Enterococcus, Clostridium sp.. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Synonym:Meropenem Trihydrate
US brand name:Merrem I.V.
Code names:SM-7338
SM-7338



Previous:Menogarol, meperidine hydrochloride, Meprolone, mercaptopurine, Mercaptopurinum
Next:Merrem I.V., mesna, Mesnex, MET receptor tyrosine kinase inhibitor SGX523, Met tyrosine kinase inhibitor BMS-777607

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov